Cheryl Byers, MHA, CIP, CHRC
VP & Principal, Institutional Research CoE, Advarra
With over 20 years’ research compliance experience, Cheryl Byers is an expert in human subject research. She has provided oversight to programs such as pre-clinical, conflict of interest, HIPAA Privacy, research misconduct, institutional biosafety, radiation safety, export control, and facility security. Byers is a former AAHRPP site visitor and step 1 reviewer; is certified in healthcare research compliance; and is a certified IRB professional.
Latest Posts by Cheryl
Navigating sIRB Complexities: An Interactive Session
Join us as we share insights, strategic priorities, and guidance for preparing your institution for sIRB mandates.
Setting Yourself up for Success During Investigator-initiated Trials
This eBook shares tips and best practices to guide researchers through the investigator-initiated trial process while staying compliant.
The Current State of Study Activation and Methods to Ensure Success
This webinar will discuss the importance of protocol feasibility and identifying solutions to ensure your organization's success.
Phase I Oncology Clinical Trials
This blog discusses what makes Phase I oncology trials complex and what IRBs need to know as they review a Phase I trial.
Cheryl Byers and Dr. John H. Stewart Discuss Diversity, Equity and Inclusion in Cancer Research
Diversity, equity, and inclusion (DEI) in cancer research are critical to clinical research. In this episode, Advarra’s Cheryl Byers and Dr. John H. Stewart have a discussion on what is DEI, the current climate of DEI in cancer research, and considerations to improve DEI in clinical trial enrollment and retention.
Q&A Part II: Clinical Trial Feasibility: Ensuring Success for Clinical Sites
Part 2 of Q&A from the Clinical Trial Feasibility: Ensuring Success for Clinical Sites webinar outlining why it is important for sites to approach research operations as a business.
Q&A Part I: Clinical Trial Feasibility: Ensuring Success for Clinical Sites
Q&A from the Clinical Trial Feasibility: Ensuring Success for Clinical Sites webinar outlining why it is important for sites to approach research operations as a business.
Legislation to Advance Equality and Inclusion in Oncology Clinical Trials
The Clinical Treatment Act and Henrietta Lacks Enhancing Cancer Research Act aims to increase diversity in oncology clinical trials
Clinical Trial Feasibility: Ensuring Success for Clinical Sites
With comprehensive research portfolios and a myriad of operational challenges to manage, it has never been more important for sites to approach research operations as a business.
Community-Based Participatory Research (CBPR): A Framework for Community Engagement
Community-based participatory research (CBPR) is utilized to reduce racial and ethnic health disparities in under-represented populations.